Advertisements

Transplant Diagnostics Market Highlighting Regional Revenue Share Dominance during 2019-2023

Global Transplant Diagnostics Market report explores future trends for supply, demand and market growth rate, market size, prices, trading, competition and value chain as well as Key Players of the industry’s information with forecast from 2019 to 2023.

Global Transplant Diagnostics Market Synopsis:

This report studies the Transplant Diagnostics Market over the forecast period of 2019 to 2023. The Transplant Diagnostics Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2019 to 2023.

Some of the key participants in Transplant Diagnostics Market are BD, Biofortuna, Biomérieux SA, Bio-Rad Laboratories, Caredx, F. Hoffman-La Roche, Gendx, Hologic, Illumina, Immucor, Luminex, Merck KGaA, Omixon, Qiagen, Thermo Fisher Scientific

Get Sample Study Papers of “Global Transplant Diagnostics Market” @ https://www.businessindustryreports.com/sample-request/193143 .

Transplant Diagnostics Market report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Transplant Diagnostics Market by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report. The scope of the report includes a detailed study of Transplant Diagnostics Market with the reasons given for variations in the growth of the industry in certain regions.

The adoption of transplant diagnostics (including both pre- and post-transplant screening) is expected to witness a significant rise with increasing prevalence of chronic diseases that can lead to organ failure. The market has gained the interest of healthcare providers owing to various benefits offered by these tests to assess the feasibility of the organ transplant procedure. There have been significant technological advancements in transplant diagnostics to provide advanced diagnostics options for the management of organ transplant.

As per Regional Analysis, North America dominates the global market for transplant diagnostics due to continuous reduction in the average cost of gene sequencing, private-public funding for the development of HLA typing technology and rising number of stem cells, and solid organ-based transplantation in the region.

Market by Type

  1. Solid Organ Transplantation
  2. Stem Cell Transplantation
  3. Soft Tissue Transplantation

Transplant Diagnostics market – By Application

  1. Independent Reference Laboratories
  2. Hospitals & Transplant Centers
  3. Research Laboratories & Academic Institutes

A complete analysis of the competitive landscape of the Global Transplant Diagnostics Market is provided in the report. This section includes company profiles of market key players. The profiles include contact information, gross, capacity, product details of each firm, price, and cost. This report investigates new project feasibility with a purpose of enlightening new entrants about the possibilities in this market. In this report, thorough SWOT analysis & investment analysis is provided which forecasts imminent opportunities for the Transplant Diagnostics Market players.

Industry News:

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announces AlloSure received a positive draft Local Coverage Determination (dLCD) for Medicare coverage in heart transplant patients.

The Centers for Medicare and Medicaid Services (CMS) released the draft version of the coverage policy issued by Palmetto GBA, the Medicare administrator responsible for the MolDX technology assessment program that evaluated AlloSure. Forty percent of heart transplant patients are covered by Medicare.

“AlloSure provides additional insights into antibody mediated rejection in heart transplant patients, an indication that is growing in our patient population,” said Dr. Jonathan Kobashigawa, Medical Director at Cedars Sinai. “When paired with AlloMap, we have a strong tool for patient surveillance through the life of their allograft.”

“We have some strong early experience with HeartCare where clinicians are seeing the value of AlloSure and AlloMap in patient management,” said Peter Maag, CEO of CareDx.  “MolDX’s draft coverage underscores the value we bring to transplant patient care.”

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Transplant Diagnostics Market Report 2019” @ https://www.businessindustryreports.com/buy-now/193143/single .

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Transplant Diagnostics in these regions, from 2014 to 2023 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America.

Transplant Diagnostics Market Questions Answered in this Report:

1  What are the major market drivers, challenges, and opportunities in the global Transplant Diagnostics Market?

2  What was the market value of the leading segments and sub-segments of the global Transplant Diagnostics Market in 2018?

3  How will each segment of the global Transplant Diagnostics Market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2023?

4  What are the influencing factors that may affect the market share of the key players?

5  How will the industry evolve during the forecast period 2019-2023?

6  Who are the key players in the Transplant Diagnostics Market and end user market and what are their contributions?

Major Points in Table of Contents:

Table of Contents

Section 1 Transplant Diagnostics Product Definition

Section 2 Global Transplant Diagnostics Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Transplant Diagnostics Shipments

2.2 Global Manufacturer Transplant Diagnostics Business Revenue

2.3 Global Transplant Diagnostics Market Overview

Section 3 Manufacturer Transplant Diagnostics Business Introduction

3.1 BD Transplant Diagnostics Business Introduction

3.1.1 BD Transplant Diagnostics Shipments, Price, Revenue and Gross profit 2014-2018

3.1.2 BD Transplant Diagnostics Business Distribution by Region

………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

Advertisements

Leave a Reply

%d bloggers like this: